Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mitsubishi Chemical Group's other long-term liabilities for the quarter that ended in Jun. 2026 was €2,500 Mil.
Mitsubishi Chemical Group's quarterly other long-term liabilities
increased
from Dec. 2025 (€2,091 Mil) to Mar. 2026 (€2,519 Mil) but then
declined
from Mar. 2026 (€2,519 Mil) to Jun. 2026 (€2,500 Mil).
Mitsubishi Chemical Group's annual other long-term liabilities
declined
from Mar. 2024 (€2,478 Mil) to Mar. 2025 (€2,469 Mil) but then
increased
from Mar. 2025 (€2,469 Mil) to Mar. 2026 (€2,519 Mil).
Mitsubishi Chemical Group Other Long-Term Liabilities Related Terms
Mitsubishi Chemical Group Other Long-Term Liabilities Historical Data
* Premium members only.
The historical data trend for Mitsubishi Chemical Group's Other Long-Term Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mitsubishi Chemical Group Other Long-Term Liabilities Chart
Mitsubishi Chemical Group Other Long-Term Liabilities Calculation
Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.
What does a Other Long-Term Liabilities of €2,500 Mil mean?
Mitsubishi Chemical Group (FRA:M3C) has a Other Long-Term Liabilities of €2,500 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Mitsubishi Chemical Group and its competitors.
Is Mitsubishi Chemical Group's Other Long-Term Liabilities too high?
Mitsubishi Chemical Group's current Other Long-Term Liabilities is €2,500 Mil. Overall, Mitsubishi Chemical Group has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mitsubishi Chemical Group's Other Long-Term Liabilities compare to LIN and SHW?
Mitsubishi Chemical Group's Other Long-Term Liabilities of €2,500 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Chemicals company?
A good Other Long-Term Liabilities depends on the Chemicals industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Mitsubishi Chemical Group and its competitors. Mitsubishi Chemical Group's current Other Long-Term Liabilities is €2,500 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mitsubishi Chemical Group stock overvalued right now?
Based on GuruFocus' analysis, Mitsubishi Chemical Group (FRA:M3C) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.54, compared to a current price of €6.71 — trading 47.8% above its estimated fair value. The current Other Long-Term Liabilities is €2,500 Mil. Mitsubishi Chemical Group's overall GF Score™ is 62/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Mitsubishi Chemical Group (FRA:M3C), the current Other Long-Term Liabilities is €2,500 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mitsubishi Chemical Group (FRA:M3C) Overvalued in 2026?
Based on GuruFocus' analysis, Mitsubishi Chemical Group stock appears to be overvalued.
The current stock price of €6.71 is trading 47.8% above its estimated GF Value™ of €4.54.
GuruFocus considers Mitsubishi Chemical Group to be Significantly Overvalued.
Key valuation signals for FRA:M3C:
Other Long-Term Liabilities: €2,500 Mil
GF Value™: €4.54 vs. price of €6.71 (47.8% above fair value)
No single metric tells the full story. See the FRA:M3C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mitsubishi Chemical Group Corp is a holding company which manufactures and sells chemicals, plastics, and pharmaceuticals. It organizes itself into five segments. The Basic Materials & Polymers segment covers petrochemical substrates, polyolefins, basic chemicals, sustainable polymers, engineering plastics, and carbon. The Industrial Gas segment focuses on industrial gases. The MMA & Derivatives segment includes MMA, PMMA, coatings, additives, and fine chemicals. The Pharmacy segment is engaged in medicines, and the Specialty Materials segment handles advanced films and polymers, advanced solutions, and advanced composites. The Others segment includes businesses such as engineering, transportation, and warehousing. It generates the majority of its revenue from the Industrial gas segment.
62GF Score
Get the complete analysis for FRA:M3C
Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3C has been successfully added to your 
